期刊文献+

米非司酮伴米索前列醇改良式药物流产的药物经济学评价 被引量:1

Pharmacoeconomic Evaluation of Mifepristone with Misoprostol for Improved drug Abortion
原文传递
导出
摘要 目的评价米非司酮伴米索前列醇改良式药物流产的成本-效果。方法应用成本-效果分析法对279例(观察组)要求药物终止妊娠的早孕妇女延长米非司酮及米索前列醇使用时间3 d,与正常使用药物流产的281例早孕妇女(对照组)进行有效性和经济性比较。结果两组妇女效果分别为82.5%、94.6%;成本-效果比分别为7.369、8.136;观察组相对于对照组的增量成本-效果比为13.37。结论从药物经济学角度考虑,药物流产终止妊娠的早孕妇女延长米非司酮及米索前列醇3 d的用药方案更加有效合理。 Objective To evaluate the effect of mifepristone combined with misoprostol for improved drug abortion cost.Methods Carries on the comparative analysis for the effectiveness and economy of the 279 patiants(the observation group) who want to have medical abortion were prolonged three days for the use of mifepristone and misopprostol and the normal medical abortion(the control group).Results Effect of two groups of women were 82.5% and 94.6%;cost-effectiveness than were 7.369,8.136;observation group compared with control group the incremental cost-effectiveness ratio of 13.37.Conclusion From the point of view of drug economics,the treatment of drug abortion termination of pregnancy by mifepristone and misoprostol 3 D is more effective and reasonable.
出处 《中国药物经济学》 2015年第7期10-12,共3页 China Journal of Pharmaceutical Economics
基金 广东省人口计生委科研项目(20133099)
关键词 米非司酮 米索前列醇 药物流产 药物经济学 成本-效果分析 Mifepristone Misoprostol Medical abortion Pharmacoeconomics The cost-effective analysis
  • 相关文献

参考文献4

二级参考文献13

共引文献56

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部